| Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells. | |
| | |
MedLine Citation:
|
PMID: 7807964 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Mesangial changes in a variety of pathologic conditions involve mesangial cell proliferation and mesangial matrix remodelling. Heparin has been shown to prevent these processes in vivo. In vitro, heparin interferes with cell growth, proto-oncogene expression, synthesis of specific proteins, and extracellular matrix composition. In some cell types, it seems to interact with intracellular protein kinase C-dependent pathways. The effect of heparin on the mesangial plasminogen activating system (tissue type plasminogen activator, t-PA, and plasminogen activator inhibitor type 1, PAI-1), which is thought to be involved in matrix remodelling, has not been previously reported. EXPERIMENTAL DESIGN: Cultured human mesangial cells were stimulated by 10% fetal calf serum (FCS) or 16 nM phorbol myristate acetate (PMA) in the presence or absence of anticoagulant or nonanticoagulant heparins. Cell proliferation, synthesis of t-PA and PAI-1, cell morphology, and PAI-1 matrix deposition were studied using cell counting, [3H]thymidine incorporation, specific t-PA and PAI-1 enzyme-linked immunosorbent assay, Northern blot analysis, light microscopy, immunofluorescence and immunogold silver staining with combined bright-field and epipolarization microscopy. RESULTS: Heparin partially inhibited FCS-stimulated cell growth but not PMA-induced thymidine incorporation. FCS and PMA stimulated t-PA (p < 0.05 and p < 0.01, respectively) and PAI-1 synthesis (p < 0.05 and p < 0.01 respectively). Heparin selectively and partially inhibited FCS-stimulated t-PA, but not PAI-1 synthesis. It has no effect on PMA-stimulated t-PA or PAI-1 synthesis but prevented cell shape-changes induced by PMA, suggesting that heparin inhibits some but not all protein kinase C (PKC)-dependent effects and that heparin block in t-PA synthesis is distal to PKC activation. Heparin decreased PAI-1 matrix accumulation. Similar distal to PKC activation. Heparin decreased PAI-1 matrix accumulation. Similar results were observed with anticoagulant and nonanticoagulant heparin fragments. CONCLUSIONS: In human mesangial cells, anticoagulant and nonanticoagulant heparin exert an antiproliferative effect and may prevent mesangial matrix changes by decreasing FCS-stimulated t-PA synthesis and PAI-1 deposition in the matrix. Heparin is able to inhibit PKC-dependent cell shape changes but not PKC-dependent t-PA or PAI-1 synthesis. It also inhibits PKC-independent cell proliferation and t-PA synthesis. These results suggest multiple intracellular sites of action for heparin, unrelated or distal to PKC activation. |
| | |
Authors:
|
J Hagège; F Delarue; M N Peraldi; J D Sraer; E Rondeau |
Related Documents
:
|
21357034 - Protein arrays: probing the array and detecting radioactive spots for kinase-substrate ... 1311574 - Phosphorylation of a surface receptor bound urokinase-type plasminogen activator in a h... 7769094 - Tissue plasminogen activator (tpa) inhibits plasmin degradation of fibrin. a mechanism ... 21147854 - Serum- and glucocorticoid-inducible kinase 1 (sgk1) controls notch1 signaling by downre... 8626464 - Cellular phosphorylation of anti-hiv nucleosides. role of nucleoside diphosphate kinase. 7559804 - Protein kinase a regulates the degradation rate of rs acetylcholine receptors. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Laboratory investigation; a journal of technical methods and pathology Volume: 71 ISSN: 0023-6837 ISO Abbreviation: Lab. Invest. Publication Date: 1994 Dec |
Date Detail:
|
Created Date: 1995-01-27 Completed Date: 1995-01-27 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0376617 Medline TA: Lab Invest Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 828-37 Citation Subset: IM |
Affiliation:
|
Inserm U 64 and Association Claude Bernard, Hôpital Tenon, Paris, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Blotting, Northern Cell Division / drug effects Cells, Cultured Enzyme-Linked Immunosorbent Assay Glomerular Mesangium / cytology, drug effects* Heparin / chemistry, pharmacology* Heparitin Sulfate / pharmacology Humans Immunohistochemistry Microscopy, Polarization Plasminogen Activator Inhibitor 1 / biosynthesis*, immunology Tetradecanoylphorbol Acetate / pharmacology Tissue Plasminogen Activator / biosynthesis* |
| Chemical | |
Reg. No./Substance:
|
0/Plasminogen Activator Inhibitor 1; 16561-29-8/Tetradecanoylphorbol Acetate; 9005-49-6/Heparin; 9050-30-0/Heparitin Sulfate; EC 3.4.21.68/Tissue Plasminogen Activator |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Neointima and arterial injury: dogs, rats, pigs, and more.
Next Document: Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human place...